Feature | Radial Access | March 06, 2013 | Dave Fornell

The Economic Benefits of Transradial Access

Changing the access site may provide major cost savings and enable same-day PCI programs

The economic benefits of radial, transradial access for PCI  coronary interventions

There has been much discussion about how use of transradial access may help reduce costs by cutting hospital admissions, length of stay and observation periods, while also reducing bleeding complications and the need for transfusions. Few centers could offer hard numbers showing these savings, however empirical evidence is now surfacing that these statements are true. The numbers show that transradial programs are impacting several hospitals’ bottom lines. 

The economic impact of several transradial programs was shared during a session at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) meeting.  

Key Selling Points

Transradial access lowers bleeding complication rates, access closure is more reliable with pressure alone without the need for closure devices, and earlier patient ambulation helps reduce the nursing time required per patient, said Adhir Shroff, M.D., MPH, assistant professor of medicine, director, cardiac cath lab, University of Illinois at Chicago (UIC).  

To demonstrate how this translates into savings and efficiency for hospitals, Shroff used the example of his own cath lab.  The average time spent using radial access for diagnostic catheterizations is 54.6 minutes, opposed to 72.5 for transfemoral access. For PCI, transradial cases average 47.2 minutes, as opposed to 91.7 for femoral access. UIC performs about 2,000 PCIs annually, and if all were performed transradial, Shroff said it would save about 980 hours of cath lab time per year. At a cost of $48.40 per hour for use of the cath lab, the financial savings would be close to $50,000 per year. 

UIC also found there was an average savings of $1,716 per case when radial access was used (transfemoral costs about $12,714, radial access costs about $10,997 at UIC). If all PCIs were performed by radial access, the savings would be about $3.4 million a year. 

“I think that kind of savings by just changing the access site is really impressive,” Shroff said. “It’s a quick message that is easy to break down to show the benefits.”

Savings Seen at Other Centers

The Medical University of South Carolina (MUSC) started its transradial program in 2009 and made it routine, said Daniel Steinberg, M.D., assistant professor of medicine, interventional cardiology, associate director of the South Carolina Valve Center, MUSC. While the learning curve for new transradial operators increased procedure times, fluoro and contrast use, their bleeding complication rate dropped by 50 percent in the first year, he explained.  Today MUSC performs about 60 percent of its PCIs using transradial access. 

MUSC linked its use of femoral and radial access to billing to track cost comparisons and found reductions in direct and indirect costs, and length of stay for radial access. “We are saving about $1,200 per case using transradial access,” Steinberg said. 

While the conversion to radial has saved money, MUSC also hoped to see additional savings with its use for a same-day PCI program. Steinberg said the original version of same-day PCI protocols were too restrictive.  This resulted in only two patients who were actually discharged on the day of their procedures during the first several months of the program. 

The Frederik Meijer Heart and Vascular Institute, Grand Rapids, Mich., has about 3,300 PCI cases annually.  The center began tracking its use of access sites and found a savings of about $1,900 per patient using transradial, said David Wohns, M.D., FACC, FSCAI, director, interventional cardiology and vascular interventions, Frederik Meijer Heart and Vascular Institute. He said this savings was partly due to reducing the length of stay to about half a day. 

The trend at all hospitals monitoring costs per patient by access sites found similar savings of at least $1,000. Wohns said St. Luke’s Mid America Heart Institute in Kansas City, Mo., realized a savings of $1,100 per patient. Shroff said radial access saved about $1,000 per patient in the EASY study, which included 1,005 patients who underwent transradial PCI.[1]

The Changing Reimbursement Landscape

There is no doubt that healthcare reform will favor programs that can reduce length of stay, use of resources and complications. This will eventually translate into reimbursement restructuring that favors outpatient programs. 

“There has been a big shift in the landscape to same-day PCIs,” Shroff said, explaining CMS is promoting outpatient migration for PCI. “Transradial PCI provides value for an outpatient PCI program. Also, there is no doubt in my mind that patients prefer transradial.”

In addition, Shroff said Medicare does not reimburse for observational costs, so there is no monetary difference between monitoring a PCI patient for eight hours as opposed to 23 hours. 

Diagnosis-related group (DRG) reimbursements for inpatient and outpatient PCI is closing, Shroff said, with rates of about $10,000 for inpatient and $7,500 for outpatient. 

CMS utilizes recovery audit contractors (RACs) to detect and correct past improper payments so CMS and insurance carriers can implement actions that will prevent future improper payments. Of the RACs performed, seven out of 10 are for cardiovascular procedures due to the high costs related to cardiolvascular care. 

Following RAC audits, centers observe a 30 percent increase in outpatient PCI. Shroff said after these audits, centers find that there are many PCI patients who can be treated under the outpatient classification, who probably were incorrectly classified as “inpatients” before.

“One of the things we want to do is be proactive before we undergo a RAC audit,” Shroff said. 

Complications Drive Up Costs

In numerous studies, radial access has been shown to increase patient safety by reducing bleeding complications. This fact alone is the main reason many operators switch to the radial artery. Wohns said the overall cost savings for radial access comes from its ability to prevent complications. Even if access site bleeding complications are rare, they add significant costs to a hospital’s bottom line.  “Complications we know inarguably increase our costs,” Wohns said. 

He admits there is a learning curve and realizes many operators are not comfortable doing something they were not trained for in medical school. However, he said it gets easier the more operators use the technique. Steinberg said from MUSC’s experience it takes about 50 PCI cases before operators become proficient at radial procedures.

Shroff said radial complication rates are very low, with radial occlusion being the most prevalent in about 5 percent of patients. However, he said this, too, could largely be avoided with the use of an Allen’s test prior to the procedure. 

Radial access is widely used outside the United States, where it is included as part of interventional cardiology training programs. In 2008, a study of the National Cardiovascular Data Registry (NCDR) found radial PCO accounted for about 1.3 percent of all cases in the United States.[2]  There has been a big push in recent years to increase its usage and today it is estimated that transradial is used in nearly 15 percent of PCIs, Shroff said.   

 

Other Radial Access Information Sources on DAIC

How to Contend With Transradial Artery Perforation

Radial Access Adoption in the United States

VIDEO: Update on U.S. Transradial Access Adoption With Sunil Rao at TCT 2015

Eight Tips to Make Radial Access Successful

Radial Access May Offer Cost Savings

Patient Satisfaction and Complications of Transradial Catheterization

VIDEO: Radial Access Recovery Lounge Mimics Cafe Atmosphere

The Economic Benefits of Transradial Access

Tips When Prepping for Radial Procedures

Prepping Patients for Radial Access Procedures

 

References: 

1. Bertrand OF, De Larochelliere R, Rodes-Cabau J, et al. “Early Discharge After Transradial Stenting of Coronary Arteries (EASY) Study Investigators. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.” Circulation. 2006 Dec 12; 114(24): 2636-43. Epub 2006 Dec 4.

2. Sunil V. Rao, Fang-Shu Ou, Tracy Y. Wang, et al. “Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention.” J Am Coll Cardiol Intv. 2008;1(4): 379-386. doi:10.1016/j.jcin.2008.05.007.


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now